AAMU
ABMD

AEGON Asset Management (UK)’s Abiomed Inc ABMD Stock Holding History

AEGON Asset Management (UK)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-141,596
Closed -$34.8M – 173
2022
Q3 		$34.8M Buy
141,596
+1,085
+0.8% +$293K 0.7% 49
2022
Q2 		$34.8M Sell
140,511
-3,672
-3% -$991K 0.66% 47
2022
Q1 		$47.7M Buy
144,183
+7,349
+5% +$2.26M 0.7% 43
2021
Q4 		$49.1M Buy
136,834
+12,256
+10% +$4.14M 0.63% 46
2021
Q3 		$40.6M Buy
124,578
+2,129
+2% +$721K 0.58% 52
2021
Q2 		$38.2M Buy
122,449
+3,810
+3% +$1.17M 0.54% 61
2021
Q1 		$37.8M Buy
118,639
+10,934
+10% +$3.5M 0.56% 58
2020
Q4 		$34.9M Buy
107,705
+5,888
+6% +$1.63M 0.51% 67
2020
Q3 		$28.2M Buy
+101,817
New +$29.3M 0.57% 58

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AEGON Asset Management (UK)'s ABMD Position: Q4 2022 in Review

AEGON Asset Management (UK) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 141,596 shares — an estimated $34.8M sold.

AEGON Asset Management (UK) first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $49.1M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • AEGON Asset Management (UK) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 141,596 Abiomed Inc shares in Q4 2022, an estimated $34.8M.
  • AEGON Asset Management (UK) first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • AEGON Asset Management (UK)'s Abiomed Inc position peaked at $49.1M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AEGON Asset Management (UK)'s 13F filing for Q4 2022, filed 17 Jan 2023.